Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes show promise in dermatology but need more research and FDA approval for clinical use.

Nanocarriers can enhance cosmetics but face regulatory and safety challenges.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

TRM21 helps control flavonoid production and root hair growth in Arabidopsis thaliana.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

3D-printed microneedles improve drug delivery and diagnostics but face scalability and regulatory challenges.

Haloperidol effectively treated hemiballismus, but spontaneous improvement wasn't ruled out; rapid weight loss can cause hair loss with good regrowth chances.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

Different countries have regulations to ensure the safety of hair care products, with some recalling hair straighteners due to high formaldehyde.

lncRNAs are important for understanding and treating skin diseases.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

The HOXC13 gene affects different hair proteins in cashmere goats in varied ways and is controlled by a feedback loop and other factors.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

Fat from the body can help improve hair growth and scars when used in skin treatments.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Public health decisions should rely on independent trials, not biased literature.

A new method found unlisted drugs in two popular hair serums, posing a health risk.